NeuroMetrix Inc (NURO)

0.61
0.01 1.60
NASDAQ : Health Care
Prev Close 0.62
Open 0.62
Day Low/High 0.61 / 0.62
52 Wk Low/High 1.35 / 4.96
Volume 6.12K
Avg Volume 175.40K
Exchange NASDAQ
Shares Outstanding 7.91M
Market Cap 5.07M
EPS -7.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

NeuroMetrix Reports Q4 And Full Year 2016 Financial Results

NeuroMetrix Reports Q4 And Full Year 2016 Financial Results

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW), today reported financial and business highlights for the quarter and year ended December 31, 2016.

NeuroMetrix, Inc. Announces Date For 2016 Full Year And Fourth Quarter Financial Results Conference Call

NeuroMetrix, Inc. Announces Date For 2016 Full Year And Fourth Quarter Financial Results Conference Call

NeuroMetrix, Inc. (NASDAQ: NURO, NUROW) announced today that it plans to issue its 2016 full year and fourth quarter financial results before the opening of the market on January 26, 2017.

NeuroMetrix Reports Strong Quell Demand In Q4 2016

NeuroMetrix Reports Strong Quell Demand In Q4 2016

NeuroMetrix, Inc. (the "Company") (Nasdaq: NURO, NUROW) reported Q4 2016 demand highlights for its Quell ® Wearable Pain Relief Technology™.

NeuroMetrix To Present At The Digital Medicine Showcase 2017: At The Intersection Of Technology And Medicine

NeuroMetrix To Present At The Digital Medicine Showcase 2017: At The Intersection Of Technology And Medicine

NeuroMetrix, Inc. (NASDAQ:NURO, NUROW) today announced that Shai N.

NeuroMetrix Closes $7.0 Million Private Placement Of Preferred Stock And Warrants

NeuroMetrix Closes $7.0 Million Private Placement Of Preferred Stock And Warrants

NeuroMetrix, Inc. (NASDAQ: NURO, NUROW) announced that it has closed its previously announced private placement to a healthcare dedicated institutional investor of 7,000 shares of Series E convertible preferred stock at a...

NeuroMetrix To Present At Biotech Showcase 2017

NeuroMetrix To Present At Biotech Showcase 2017

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) announced today that Shai N.

CES 2017: NeuroMetrix Brings Life-Enhancing Technology To Those Suffering From Chronic Pain

CES 2017: NeuroMetrix Brings Life-Enhancing Technology To Those Suffering From Chronic Pain

NeuroMetrix, Inc. (Nasdaq:NURO, NUROW) today announced plans to unveil important advances to its Quell® Wearable Pain Relief Technology™ at CES 2017 (CES Unveiled, Table 128 and CES Tech West booth #43421) in...

NeuroMetrix Announces $7.0 Million Private Placement Of Preferred Stock And Warrants

NeuroMetrix Announces $7.0 Million Private Placement Of Preferred Stock And Warrants

NeuroMetrix, Inc. (NASDAQ: NURO, NUROW) announced today that it has entered into a definitive securities purchase agreement with a healthcare dedicated institutional investor in connection with a private placement of...

NeuroMetrix Announces Participation In CES 2017

NeuroMetrix Announces Participation In CES 2017

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) Building on sales to over 50,000 chronic pain sufferers who have tried Quell ® since its launch in June 2015, NeuroMetrix announced today that it will unveil innovative...

NeuroMetrix Announces $26.5 Million Public Offering

NeuroMetrix Announces $26.5 Million Public Offering

NeuroMetrix, Inc. ("NeuroMetrix" or the "Company") (NASDAQ: NURO, NUROW) announced today the pricing of a public offering with expected gross proceeds from the offering of $26.

NeuroMetrix Reports Expanded Media Coverage For Quell Wearable Pain Relief

NeuroMetrix Reports Expanded Media Coverage For Quell Wearable Pain Relief

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) reported increased media attention on the company's Quell ® Wearable Pain Relief Technology ™, including an in depth report on CBS's Innovation Nation.

NeuroMetrix Announces That Quell Is Featured In Huffington's New Thrive Global Platform

NeuroMetrix Announces That Quell Is Featured In Huffington's New Thrive Global Platform

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) announced today that its Quell ® Wearable Pain Relief Technology™ is featured in the new Thrive Global commerce platform, including the online store at ThriveGlobal.

NeuroMetrix President And Chief Executive Officer Dr. Gozani To Speak At 2016 Connected Health Conference

NeuroMetrix President And Chief Executive Officer Dr. Gozani To Speak At 2016 Connected Health Conference

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) announced today that Shai N.

NeuroMetrix Announces Quell Now Available On Amazon.com Through Amazon Launchpad

NeuroMetrix Announces Quell Now Available On Amazon.com Through Amazon Launchpad

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) announced today that the Company's Quell ® Wearable Pain Relief device is now available on Amazon Launchpad.

NeuroMetrix To Present At The LD Micro Invitational Conference On December 6, 2016

NeuroMetrix To Present At The LD Micro Invitational Conference On December 6, 2016

NeuroMetrix, Inc. (NASDAQ:NURO, NUROW) today announced that Shai N.

NeuroMetrix Receives CE Mark Certification For Quell Wearable Pain Relief Device

NeuroMetrix Receives CE Mark Certification For Quell Wearable Pain Relief Device

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) announced today that the CE (Conformité Européenne ) Certificate for Quell ® has been received from TUV SUD Product Service GmbH, which is one of the...

NeuroMetrix Announces That Quell Will Be Featured On The Henry Ford Innovation Nation

NeuroMetrix Announces That Quell Will Be Featured On The Henry Ford Innovation Nation

NeuroMetrix, Inc. (Nasdaq: NURO,NUROW) announced today that its Quell ® Wearable Pain Relief Technology™ will be featured on the November 26 th episode of The Henry Ford Innovation Nation which airs on the...

NeuroMetrix' Quell Device Makes Second Appearance At American Society Of Regional Anesthesia's Annual Pain Medicine Meeting

NeuroMetrix' Quell Device Makes Second Appearance At American Society Of Regional Anesthesia's Annual Pain Medicine Meeting

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) announced today that Quell ® Wearable Pain Relief Technology™ will be featured for the second year in a row at the American Society for Regional Anesthesia's...

NeuroMetrix Reports DPNCheck Introduction At The Annual Meeting Of The China Diabetes Society

NeuroMetrix Reports DPNCheck Introduction At The Annual Meeting Of The China Diabetes Society

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) today reported that DPNCheck ®, a diagnostic test for peripheral neuropathy, will be introduced at the 20 th Scientific Meeting of the Chinese Diabetes Society during November...

NeuroMetrix Chief Commercial Officer Frank McGillin To Present Quell Wearable Pain Relief Technology At 16th Annual Diabetes Technology Meeting

NeuroMetrix Chief Commercial Officer Frank McGillin To Present Quell Wearable Pain Relief Technology At 16th Annual Diabetes Technology Meeting

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) announced today that Senior Vice President and Chief Commercial Officer Frank McGillin will present on Quell ® Wearable Pain Relief Technology™ during the 16th Annual...

NeuroMetrix Announces Promotion Of Frank McGillin To Chief Commercial Officer

NeuroMetrix Announces Promotion Of Frank McGillin To Chief Commercial Officer

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) announced today that it has promoted Frank McGillin to Senior Vice President and Chief Commercial Officer.

NeuroMetrix Announces Issuance Of New U.S. Patent For Quell Wearable Pain Relief Technology

NeuroMetrix Announces Issuance Of New U.S. Patent For Quell Wearable Pain Relief Technology

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) announced today that the U.

NeuroMetrix To Present At 2016 Sidoti Emerging Growth Convention

NeuroMetrix To Present At 2016 Sidoti Emerging Growth Convention

NeuroMetrix, Inc. (NASDAQ:NURO, NUROW) announced today that Shai N.

NeuroMetrix Reports Q3 2016 Financial Results

NeuroMetrix Reports Q3 2016 Financial Results

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW), today reported financial and business highlights for the quarter and nine month periods ended September 30, 2016.

NeuroMetrix Announces Participation At The 2016 Partners Connected Health Symposium

NeuroMetrix Announces Participation At The 2016 Partners Connected Health Symposium

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) reported today that it will be an active participant at the Connected Health Symposium on October 20-21 in Boston sponsored by Partners Healthcare.

NeuroMetrix, Inc. Announces Date For 2016 Third Quarter Financial Results Conference Call

NeuroMetrix, Inc. Announces Date For 2016 Third Quarter Financial Results Conference Call

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) announced today that it plans to issue its 2016 third quarter financial results before the opening of the market on Thursday, October 20, 2016.

NeuroMetrix Announces Participation In Discover Blue: New York City Bluetooth Event

NeuroMetrix Announces Participation In Discover Blue: New York City Bluetooth Event

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) reported today that it has been selected to showcase Quell ® Wearable Pain Relief Technology™ at the Discover Blue: New York City event hosted by the Bluetooth Special...

NeuroMetrix To Present At 5th Annual Diabetic Peripheral Neuropathy Fellowship For Chinese Physicians At The University Of Sheffield

NeuroMetrix To Present At 5th Annual Diabetic Peripheral Neuropathy Fellowship For Chinese Physicians At The University Of Sheffield

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) today announced that Dr.